3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Endocrine
1
Conditions
Neuroendocrine Tumors
7
Carcinoma, Neuroendocrine
6
Thyroid Neoplasms
2
Thyroid Carcinoma, Anaplastic
2
Lung Neoplasms
2
Gastro-enteropancreatic neuroendocrine tumor
2
Carcinoma, Non-Small-Cell Lung
2
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neuroendocrine Neoplasms
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 2a
1
Lethal Congenital Contracture Syndrome 2
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Extrapulmonary Neuroendocrine Cancer
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Central Nervous System Neoplasms
1
Carcinoma, Small Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Large Cell
1
Interventions
osimertinib
1
cemiplimab
1
Vascular Endothelial Growth Factor A
1
Paclitaxel
1
Docetaxel
1
Carboplatin
1
Antibodies, Bispecific
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lethal Congenital Contracture Syndrome 2
×
Carboplatin
×
Endocrine
×
Clear all
NCT05142189
2026-04-14
LuCa-MERIT-1
BioNTech SE
Phase 1
Recruiting
320 enrolled